Literature DB >> 26526169

DNA shuffling of uricase gene leads to a more "human like" chimeric uricase with increased uricolytic activity.

Jing Chen1, Nan Jiang1, Tao Wang2, Guangrong Xie1, Zhilai Zhang1, Hui Li1, Jing Yuan3, Zengxian Sun4, Jianhua Chen5.   

Abstract

Urate oxidase (Uox) is the enzyme involved in purine metabolism. Pseudogenization of Uox gene is the underlying mechanism of hyperuricemia and gout in human. Although Uox from various microorganisms has been used in clinical practice for many years, its application is limited by potential immunogenicity. In order to develop a more "human like" uricase, DNA shuffling was used to create chimeric uricase with both improved enzymatic activity and increased homology with deduced human uricase (dHU) gene. By using wild porcine uricase (wPU) gene and dhu as parental genes, a diverse chimeric library was generated. After preliminary screening by a "homebrew" high throughput protocol, approximately 100 chimeras with relatively high enzymatic activity were obtained. By further activity comparison of the purified enzymes, chimera-62 with increase in both activity and homology with dHU compared with wPU was selected. Its Km and catalytic efficiency were determined as 9.43±0.04μM and 2.67s(-1)μM(-1) respectively. There were 33 amino acid substitutions in chimera-62 when compared with dHU and 5 substitutions when compared with wPU. By homology modeling and 3-D structure analysis, it was speculated that mutations G248S and L266F contributed to the increased activity of chimera-62 by increasing the stability of α-helix and surface polarity respectively.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA shuffling; High-throughput screening; Urate oxidase

Mesh:

Substances:

Year:  2015        PMID: 26526169     DOI: 10.1016/j.ijbiomac.2015.10.053

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

Review 1.  Design and engineering of deimmunized biotherapeutics.

Authors:  Karl E Griswold; Chris Bailey-Kellogg
Journal:  Curr Opin Struct Biol       Date:  2016-06-17       Impact factor: 6.809

Review 2.  Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).

Authors:  Diana Raquel Rodríguez-Rodríguez; Ramiro Ramírez-Solís; Mario Alberto Garza-Elizondo; María De Lourdes Garza-Rodríguez; Hugo Alberto Barrera-Saldaña
Journal:  Int J Mol Med       Date:  2019-02-26       Impact factor: 4.101

3.  Combinatorial approach for screening and assessment of multiple therapeutic enzymes from marine isolate Pseudomonas aeruginosa AR01.

Authors:  Yogeswaran Jagadeesan; Shanmugapriya Meenakshisundaram; Lokha Ranjani Alagar Boopathy; Vijay Pradhap Singh Mookandi; Anandaraj Balaiah
Journal:  RSC Adv       Date:  2019-05-31       Impact factor: 4.036

4.  Development of Therapeutic Chimeric Uricase by Exon Replacement/Restoration and Site-Directed Mutagenesis.

Authors:  Guangrong Xie; Weizhen Yang; Jing Chen; Miaomiao Li; Nan Jiang; Baixue Zhao; Si Chen; Min Wang; Jianhua Chen
Journal:  Int J Mol Sci       Date:  2016-05-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.